1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2022Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+ early breast cancerANNALS OF ONCOLOGY
2022Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinomaJOURNAL OF CLINICAL ONCOLOGY
2022Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2022Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST TrialCIRCULATION
2022ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinibANNALS OF ONCOLOGY
2022Elacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALDANNALS OF ONCOLOGY
2022Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets KOREAN CIRCULATION JOURNAL
2022Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter PLOS ONE
2022Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis JOURNAL OF PERSONALIZED MEDICINE
2022Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry RHEUMATOLOGY AND THERAPY
2022Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052ANNALS OF ONCOLOGY
2022Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial JOURNAL OF CLINICAL HYPERTENSION
2022Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trialJOURNAL OF CLINICAL ONCOLOGY
2022Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial CLINICAL JOURNAL OF PAIN
2022Effects of screening and treatment improvement on colon cancer survival over 20 years in KoreaANNALS OF ONCOLOGY
2022Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice ELIFE
2022Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of LobeglitazoneCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2022Effect of Stenting Strategy on the Outcome in Patients with Non-Left Main Bifurcation Lesions JOURNAL OF CLINICAL MEDICINE
2022Early experience of combining immune checkpoint inhibitor and radiotherapy in heavily pretreated hepatobiliary cancerJOURNAL OF CLINICAL ONCOLOGY
2022Durvalumab + chemotherapy in patients (pts) with advanced EGFR mutation-positive (EGFRm) NSCLC whose disease progressed on first-line (1L) osimertinib: An ORCHARD study interim analysisANNALS OF ONCOLOGY

Recent Submissions

Browse

Links